Cost-effectiveness of cardiac positron emission tomography in the treatment of ischemic cardiomyopathy.
Department of Molecular and Medical Pharmacology, UCLA School of Medicine 90095-1735, USA.
H R
HR
Schelbert
D000465:Algorithms; D001026:Coronary Artery Bypass; D003362:Cost-Benefit Analysis; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D009200:Myocardial Contraction; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D009204:Myocardial Revascularization; D013318:Stroke Volume; D014055:Tomography, Emission-Computed / Q000191:economics*; D016277:Ventricular Function, Left